Search

Your search keyword '"Juvet, Tristan"' showing total 39 results

Search Constraints

Start Over You searched for: Author "Juvet, Tristan" Remove constraint Author: "Juvet, Tristan"
39 results on '"Juvet, Tristan"'

Search Results

2. Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched Analysis

5. Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care Metrics

6. Cost-effectiveness of Retrograde Intrarenal Surgery, Standard and Mini Percutaneous Nephrolithotomy, and Shock Wave Lithotripsy for the Management of 1-2cm Renal Stones

7. Reply by Authors

8. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-Analysis

10. MP68-04 A FIVE—GENE DNA—METHYLATION BIOMARKER PANEL SENSITIVELY DETECTS BLADDER CANCER AND DISCRIMINATES BETWEEN HIGH—GRADE AND LOW—GRADE DISEASE IN VOIDED URINE

11. MP61-01 FUNCTIONAL ROLE OF THE KALLIKREIN 6 REGION OF THE KALLIKREIN LOCUS IN GENETIC PREDISPOSITION FOR AGGRESSIVE (GLEASON ≥8) PROSTATE CANCER: FINE-MAPPING AND METHYLATION STUDY IN A CANADIAN COHORT AND THE SWISS ARM OF THE EUROPEAN RANDOMIZED STUDY FOR PROSTATE CANCER SCREENING

13. FINE-MAPPING OF THE KALLIKREIN REGION AND ITS ROLE IN PROSTATE CANCER AGGRESSIVENESS: RESULTS FROM A CANADIAN COHORT AND THE EUROPEAN RANDOMIZED STUDY FOR PROSTATE CANCER SCREENING: MP49-20

17. Sequential administration of Bacillus Calmette-Guerin (BCG) and Electromotive Drug Administration (EMDA) of mitomycin C (MMC) for the treatment of high-grade nonmuscle invasive bladder cancer after BCG failure

18. A noninvasive urine-based methylation biomarker panel to detect bladder cancer and discriminate cancer grade

20. MP73-01 SEQUENTIAL ADMINISTRATION OF BACILLUS CALMETTE-GUERIN (BCG) AND ELECTROMOTIVE DRUG ADMINISTRATION (EMDA) OF MITOMYCIN C (MMC) FOR THE TREATMENT OF HIGH GRADE NON MUSCLE INVASIVE BLADDER CANCER AFTER BCG FAILURE

22. MP64-01 PATIENT REPORTED QUALITY OF LIFE MEASURES 15 YEARS POST-RADICAL PROSTATECTOMY: A MATCHED COMPARISON OF OPEN RETROPUBIC AND ROBOT ASSISTED TECHNIQUES

24. Percutaneous Image-guided Core Needle Biopsy for Upper Tract Urothelial Carcinoma

25. PD18-07 A NON-INVASIVE URINE-BASED METHYLATION BIOMARKER PANEL FOR BLADDER CANCER DETECTION

27. The burden of urological disease in Zomba, Malawi: A needs assessment in a sub-Saharan tertiary care center.

29. PD65-01 GERMLINE MUTATIONS IN THE KALLIKREIN 6 REGION AND PREDISPOSITION FOR AGGRESSIVE PROSTATE CANCER

31. Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer

32. Renal tumor biopsy for small renal masses: a single-center 13-year experience

33. Progressive Multifocal Leukoencephalopathy in a 62-Year-Old Immunocompetent Woman

35. MP49-20 FINE-MAPPING OF THE KALLIKREIN REGION AND ITS ROLE IN PROSTATE CANCER AGGRESSIVENESS: RESULTS FROM A CANADIAN COHORT AND THE EUROPEAN RANDOMIZED STUDY FOR PROSTATE CANCER SCREENING

37. Life-threatening Hyperkalemia: A Potentially Lethal Drug Combination.

38. Progressive Multifocal Leukoencephalopathy in a 62-Year-Old Immunocompetent Woman

39. Germline Mutations in the Kallikrein 6 Region and Predisposition for Aggressive Prostate Cancer.

Catalog

Books, media, physical & digital resources